| Application no. and date | 11702974.4 (espacenet) (Federated) (European Patent Register), 20110202 | | Patent/reg. no. and date | DK/EP 2531526, 20170816 | | Publication date | 20121212 | | Priority no. and date | GB 201001791, 20100203, GB 1001791, 20100203 | | EP pub. no. and date |
EP 2531526 20121212 | | Effective date | | | Applicant/owner | UCB Biopharma SRL, 60, Allee de la Recherche
1070 Brussels, BE | | Applicant ref. no. | 160961 | | Inventor | BILGISCHER, Jean-Pascal Pierre, c/o UCB PHARMA
IP Department
60 Allée de la Recherche
B-1070 Brussels, BE,
BASSETT, Philip Jonathan, c/o UCB CELLTECH
IP Department
208 Bath Road
Slough Berkshire SL1 3 WE, GB,
PEARCE-HIGGINS, Mark Robert, c/o UCB CELLTECH
IP Department
208 Bath Road
Slough Berkshire SL 1 3WE, GB,
KENNY, Andrew John, 21 Beechwood Road
Fishburn,
Stockton-on-Tees, TS21 4EP, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | C07K 16/00 (2006.01) | | Title | Fremgangsmåde til opnåelse af antistoffer | | Int. application no. | EP2011051450 | | Int. publication no. | WO2011095506 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
